Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Metabolite
(3R,5R)-Octahydrocurcumin is a gut microbial metabolite of Curcumin that acts as a neuroprotective agent. It demonstrates protective efficacy against Aβ25-35-induced cytotoxicity in SH-SY5Y cells and exhibits anti-inflammatory effects in LPS-stimulated mouse microglial BV-2 cells. This compound is valuable for research applications focused on neurodegenerative diseases and inflammation-related studies. -
Drug Metabolite
1-β-D-Glucosylsphingadienine (d18:2 (4E8E)) is a glucosylsphingosine derivative that serves as a key metabolite in the metabolism of glucosylcerebrosides. This compound exhibits important biological activity, influencing cellular signaling pathways and lipid metabolism. Its applications are significant in the study of lysolipid function and the pathological mechanisms underlying certain metabolic disorders. -
Drug Metabolite
2-Methylamino-1-phenylbutane hydrochloride is a primary metabolite of various stimulant agents, specifically involved in the pharmacokinetics of these compounds. This reagent is significant for research applications in toxicology and pharmacology, assisting in the analysis of drug metabolism and the assessment of stimulant effects in biological samples. Its utility extends to studies focused on understanding the biochemical pathways influenced by stimulant drugs. -
Drug Metabolite
2-Deoxokanshone M, a drug metabolite derived from Nardosinone, exhibits significant vasodilatory properties. This compound serves as a valuable tool in studying vascular biology and the pharmacokinetics of Nardosinone, contributing to research on its therapeutic applications in cardiovascular conditions. Its ability to modulate vascular tone makes it an important reagent for investigations into blood pressure regulation and related disorders. -
Drug metabolite
Isokotanin B is a metabolite derived from bicoumarin, obtained from the sclerotia of Aspergillus alliaceus. It demonstrates noteworthy biological activity against agricultural pests, specifically the corn earworm (Helicoverpa zea) and the dried fruit beetle (Carpophilus hemipterus). This compound serves as a valuable tool for research in pest management and biopesticide development. -
Drug Metabolite
N-Desmethyl-U-47700 is the primary metabolite of U-47700, functioning as an opioid receptor agonist. This compound exhibits significant analgesic properties and is relevant in research focused on opioid metabolism and pharmacokinetics. It serves as a critical tool for studying the effects and mechanisms of action associated with opioid compounds in various biological settings. -
Drug Metabolite
Silodosin Glucuronide sodium is the sodium salt of Silodosin β-D-glucuronide, a metabolite of the selective α1A-adrenergic receptor antagonist Silodosin. It exhibits high affinity for the α1A-AR, facilitating a Ki value of 0.036 nM. This compound is crucial for studying the pharmacokinetics and metabolic pathways of Silodosin, contributing to research applications in urology and cardiovascular studies. -
Drug Metabolite
Cyclo(Tyr-Val), also known as Cyclo(L-Tyr-L-Val), is a diketopiperazine secondary metabolite derived from the fungus Neurospora gilva. It has been identified for its potential role in drug metabolism studies, serving as a valuable tool for researchers investigating metabolic pathways and the pharmacokinetics of various compounds. Its unique structure and biological activity make it suitable for applications in biochemical research and drug development. -
Drug Metabolite
Buspirone N-oxide is a metabolite of Buspirone, a known 5-HT1A receptor agonist and dopamine D2 autoreceptor antagonist. This compound is significant in studying the pharmacokinetics and metabolic pathways of Buspirone. Due to its origin from an established anxiolytic agent, Buspirone N-oxide can be utilized in research related to generalized anxiety disorder and the evaluation of anxiety-modulating pathways. -
Drug Metabolite
Oxoprolintane is a primary metabolite of the psychoactive compound Prolintane, targeting the central nervous system. It plays a crucial role in the regulation of neurophysiological processes and presents potential neuroprotective properties. This compound is utilized in research focused on neurological diseases, providing insight into its therapeutic implications and mechanisms of action. -
Drug Metabolite
Tetranor-12(R)-HETE is a significant metabolite of 12(R)-HETE, formed through β-oxidation processes. This compound plays a crucial role in various metabolic pathways and has implications in studies involving lipid signaling and inflammatory responses. Its investigation can provide insights into the physiological and pathological mechanisms associated with eicosanoids. Tetranor-12(R)-HETE is useful for research applications in drug metabolism and the study of bioactive lipid mediators. -
Drug Metabolite
Carvedilol Glucuronide is a significant metabolite of the β/α-1 adrenergic receptor antagonist, Carvedilol. This compound demonstrates key biological activity by modulating β-adrenergic signaling and exhibits potential application in studying the metabolic pathway of Carvedilol. Research indicates that Carvedilol can inhibit lipid peroxidation and has properties as an antihypertensive agent, as well as an autophagy inducer that affects the NLRP3 inflammasome. Carvedilol Glucuronide serves as an important reagent for investigating drug metabolism and pharmacokinetics in cardiovascular research. -
Drug Metabolite
Florfenicol amine is the active metabolite of the veterinary antibiotic Florfenicol, known for its efficacy in combating susceptible bacterial infections in aquaculture. This compound plays a critical role in understanding the pharmacokinetics and safety of Florfenicol in various biological systems. Research applications include studying drug metabolism and evaluating the environmental impact of veterinary pharmaceuticals. -
Drug Metabolite
3-Hydroxyflunitrazepam is the principal metabolite of Flunitrazepam, formed through 3-hydroxylation by the enzyme CYP3A4. This metabolite constitutes over 80% of Flunitrazepam's metabolic pathway in liver microsomes, highlighting its relevance in pharmacokinetics. The formation of 3-Hydroxyflunitrazepam is significantly inhibited by CYP3A4 inhibitors such as Ketoconazole and Ritonavir, suggesting crucial implications for drug-drug interactions in therapeutic applications and metabolic studies. -
Omeprazole Metabolite
4-Hydroxy omeprazole sulfide is a key metabolite of the proton pump inhibitor omeprazole, primarily involved in modifying gastric acid secretion. This compound serves as a valuable tool in pharmacokinetic and metabolic studies of omeprazole and its effects on gastric mucosa. Its biological activity is significant for understanding drug metabolism and potential drug interactions in gastrointestinal research. -
Drug Metabolite
α-Hydroxy etizolam is the primary metabolite of Etizolam, exhibiting a similar pharmacological profile and high affinity for benzodiazepine receptors. This compound plays a significant role in understanding the metabolic pathways and effects of Etizolam in biological systems. It is utilized in biochemical research to investigate the pharmacodynamics and pharmacokinetics associated with anxiolytic and sedative activities. -
Drug Metabolite
Narcotoline is a phenylpyridine isoquinoline alkaloid that serves as a drug metabolite in the biosynthetic pathway of Noscapine. This compound is valuable for investigating the metabolic regulatory mechanisms associated with Noscapine, providing insights into its pharmacokinetics and biological activity. Researchers may utilize Narcotoline to explore the implications of Noscapine metabolism in various biological systems and applications. -
Drug Metabolite
4β-Hydroxycholesterol is a significant metabolite of cholesterol, functioning as a precursor in the biosynthesis of bile acids. This compound is present in human circulation and plays a crucial role in cholesterol metabolism and regulation. Its measurement can be utilized in research studies focusing on lipid metabolism, liver function, and related disorders. -
Drug Metabolite
13,14-Dihydro-19(R)-hydroxy prostaglandin E1 is a theoretical metabolite formed from 13,14-dihydro PGE1 through the action of ω-1 hydroxylase. This compound is utilized in research to explore the metabolic pathways of prostaglandins and their biological functions. Its study contributes to the understanding of the pharmacokinetics and dynamics of therapeutic agents derived from prostaglandins and their potential implications in drug metabolism. -
Drug Metabolite
15-Acetyl-deoxynivalenol-13C17 is a stable isotope-labeled form of 15-Acetyl-deoxynivalenol, a potent trichothecene toxin primarily found in cereals. This compound acts as a drug metabolite and has demonstrated significant cytotoxic effects on HepG2 liver cells. It serves as a valuable tool for studying the metabolism and toxicological impact of trichothecenes in various biological systems. -
Drug Metabolite
10-Undecen-1-ol is a drug metabolite derived from ricinoleic acid, serving as a valuable comonomer for the synthesis of functionalized polymers. This compound plays an essential role in the design of novel materials and biochemical applications, enabling the incorporation of various functional groups to enhance material properties. Its utility in chemical research positions it as a key reagent for studies involving drug metabolism and polymer chemistry. -
Furazolidone Metabolite
3-Amino-2-oxazolidinone (AOZ) is a metabolite of the antibiotic furazolidone. It serves as a reliable biomarker for detecting furazolidone residues in biological matrices, facilitating studies on drug metabolism and elimination. Due to its oral bioavailability, AOZ plays a significant role in pharmacokinetic and toxicological research applications, particularly in food safety and veterinary medicine. -
Drug Metabolite
3,4-Dimethylbenzoic acid is a drug metabolite produced during the metabolism of dimethylbenzoate by Rhodococcus rhodochrous N75. This compound serves as a significant marker in studies of biotransformation processes and can be utilized in the investigation of microbial metabolism. Its biological activity is pertinent for research applications in pharmacology and environmental microbiology, particularly in understanding the degradation pathways of aromatic compounds. -
Antioxidant Agent
Vanillylmandelic acid is a metabolic end product of epinephrine and norepinephrine, serving as a valuable indicator of neurotransmitter metabolism disorders. This compound exhibits significant antioxidant activity, effectively scavenging DPPH radicals with an IC50 value of 33 μM. It is utilized in various research applications related to oxidative stress and neurotransmitter dynamics.

